News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Sarepta Therapeutics, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
FDA
36 DMD Experts Send Letter to the FDA Urging Approval of Sarepta’s Drug
March 22, 2016
·
4 min read
Job Trends
DMD Setback Prompts Sarepta to Shutter West Coast Location and Consolidate to Massachusetts, 30 Jobs Gone
March 9, 2016
·
3 min read
Policy
With Snowmageddon Predicted for East Coast, FDA Postpones Meeting Over Sarepta’s DMD Drug
January 21, 2016
·
2 min read
Policy
FDA Turns Down Both BioMarin and Sarepta’s DMD Drug Applications, Stocks Plunge
January 15, 2016
·
3 min read
Business
Checkmate Comes Out of Stealth Mode With $20 Million and Ex-Sarepta Exec as Its Leader
August 12, 2015
·
3 min read
Policy
Investors Gear Up For Exciting News as FDA Sets Dates for BioMarin and Sarepta DMD Drugs
July 21, 2015
·
2 min read
Deals
Sarepta and BioMarin Rivalry Heats Up as Sarepta Shops for Second DMD Drug
July 14, 2015
·
3 min read
Business
Sarepta Bags Ex-Genzyme CEO as Advisor to the Company
July 1, 2015
·
6 min read
Policy
New Sarepta CEO’s Strategy Bears Fruit With NDA Filing
June 30, 2015
·
5 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 30, 2026
July 1, 2026
·
1 min read
Press Releases
Sarepta Announces FDA Acceptance of sNDAs for AMONDYS 45® and VYONDYS 53®
June 30, 2026
·
17 min read
Press Releases
Sarepta Therapeutics to Participate in Upcoming Investor Conferences
June 2, 2026
·
1 min read
Press Releases
Sarepta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
May 14, 2026
·
1 min read
Press Releases
Sarepta Therapeutics Announces First Quarter 2026 Financial Results and Recent Corporate Developments
May 7, 2026
·
19 min read
Press Releases
Sarepta Therapeutics to Announce First Quarter 2026 Financial Results
April 23, 2026
·
1 min read
Press Releases
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 31, 2026
April 1, 2026
·
1 min read
Press Releases
Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
March 25, 2026
·
9 min read
Press Releases
Sarepta to Share First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
March 25, 2026
·
1 min read
Press Releases
Sarepta Provides Regulatory Update on AMONDYS 45® and VYONDYS 53®
March 19, 2026
·
15 min read
